| 发明名称 |
USE OF ESCIN |
| 摘要 |
The present invention provides the use of escin for the manufacture of a pharmaceutical preparation for the treatment diseases mediated or caused by activated granulocytes, preferably a type I or type III allergy or septic shock. |
| 申请公布号 |
US2017014465(A1) |
申请公布日期 |
2017.01.19 |
| 申请号 |
US201615281635 |
申请日期 |
2016.09.30 |
| 申请人 |
MARINOMED BIOTECHNOLOGIE GMBH |
发明人 |
GRASSAUER Andreas T.;PRIESCHL Eva |
| 分类号 |
A61K36/77;A61K31/704;A61K9/00 |
主分类号 |
A61K36/77 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating an allergic rhinitis in a subject having allergic rhinitis, the method comprising:
topically administering a pharmaceutical composition comprising beta-escin to a mucosa of the subject, wherein the composition is formulated as a spray. |
| 地址 |
VIENNA AT |
